Maria Sharapova Failed Drug Test vs Serena Williams at Australian Open 2016 Press Conference
Maria Sharapova announced on Monday that she failed a drug test during this year's Australian Open.
Related Stories
Tennis star Sharapova faces suspension after failing drug test Reuters
Things to know about Meldonium after Sharapova fails test Associated Press
Tennis-Reactions to Maria Sharapova's positive dope test Reuters
Profile of Russia's Maria Sharapova Reuters
Doping-Swede Aregawi faces Olympic axe after failed test Reuters
25 Years Later: How The Baywatch Stars Look Today Sponsored
The Russian-born tennis star said she received a letter from the International Tennis Federation several days ago informing her that she had failed the test for meldonium during the Australian Open in January.
"I did fail the test," Sharapova told reporters at a hastily arranged press conference in Los Angeles. "And I take full responsibility for it."
The five-time Grand Slam champion said that she had been legally taking the drug, meldonium (also known as mildronate), as prescribed by a family doctor for a decade to combat a variety of illnesses while on tour.
